Atlas Trials

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2

Clinical trial NCT05203497 · COMPLETED

Trial details

NCT number
NCT05203497
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer Female
Start date
2021-12-22
Primary completion
2023-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.